Hypoxia associated biomarkers in HER2+ breast cancer cell lines for personalized therapy

Project Details


The aim of the project is to identify potential acute hypoxia-related biomarkers and therapy targets by conducting large-scale bioinformatics data analysis in the publicly available Metabric database of breast cancer multi-omics files and to verify them experimentally in HER2+ breast cancer reference cell lines.
Effective start/end date1/07/2030/06/21


  • Riga Stradins University: €20,000.00

UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This project contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being


  • hypoxia
  • breast cancer
  • HER2
  • biomarkers
  • oncology

Field of Science

  • 3.1 Basic medicine

Smart Specialization Area

  • Biomedicine, medical technologies and biotechnology


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.